ReP USP - Resultado da busca

Artigo de periodico
Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats (2022)
Marín-Prida, Javier; Liberato, José Luiz ; Llópiz-Arzuaga, Alexey; Padovani, Karina Stringhetta; Pavón-Fuentes, Nancy; Leopoldino, Andréia Machado ; Cruz, Osmany Guirola; González, Ignacio Hernández; Pérez, Mariela León; Camins, Antoni; Santos, Wagner Ferreira dos; Uyemura, Sergio Akira ; Pardo-Andreu, Gilberto L.; Pentón-Rol, Giselle
Source: Current Pharmaceutical Design. Unidades: FCFRP, FFCLRP, FMRP
Subjects: ACIDENTE VASCULAR CEREBRAL, ISQUEMIA CEREBRAL, FARMACOTERAPIA, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARÍN-PRIDA, Javier et al. Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats. Current Pharmaceutical Design, v. 28, n. 14, p. 1187-1197, 2022Tradução . . Disponível em: https://doi.org/10.2174/1381612828666220506145542. Acesso em: 23 maio 2024.
APA
Marín-Prida, J., Liberato, J. L., Llópiz-Arzuaga, A., Padovani, K. S., Pavón-Fuentes, N., Leopoldino, A. M., et al. (2022). Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats. Current Pharmaceutical Design, 28( 14), 1187-1197. doi:10.2174/1381612828666220506145542
NLM
Marín-Prida J, Liberato JL, Llópiz-Arzuaga A, Padovani KS, Pavón-Fuentes N, Leopoldino AM, Cruz OG, González IH, Pérez ML, Camins A, Santos WF dos, Uyemura SA, Pardo-Andreu GL, Pentón-Rol G. Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats [Internet]. Current Pharmaceutical Design. 2022 ; 28( 14): 1187-1197.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612828666220506145542
Vancouver
Marín-Prida J, Liberato JL, Llópiz-Arzuaga A, Padovani KS, Pavón-Fuentes N, Leopoldino AM, Cruz OG, González IH, Pérez ML, Camins A, Santos WF dos, Uyemura SA, Pardo-Andreu GL, Pentón-Rol G. Novel insights into the molecular mechanisms involved in the neuroprotective effects of C-Phycocyanin against brain ischemia in rats [Internet]. Current Pharmaceutical Design. 2022 ; 28( 14): 1187-1197.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612828666220506145542
Artigo de periodico
Feeding pattern, circadian rhythm, and immune function: what do we know about? (2022)
Estanislau, Thiago Barros ; Krüger, Karsten; Rosa Neto, José Cesar ; Padilha, Camila S. ; Gonçalves, Daniela Caetano ; Minuzzi, Luciele Guerra ; Lira, Fabio Santos
Source: Current Pharmaceutical Design. Unidade: ICB
Subjects: BIOLOGIA CELULAR, NUTRIÇÃO, OBESIDADE, ALIMENTAÇÃO, RITMOS BIOLÓGICOS, RITMO CIRCADIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESTANISLAU, Thiago Barros et al. Feeding pattern, circadian rhythm, and immune function: what do we know about?. Current Pharmaceutical Design, v. 28, n. 30, p. 2478-2487, 2022Tradução . . Disponível em: https://doi.org/10.2174/1381612828666220729091451. Acesso em: 23 maio 2024.
APA
Estanislau, T. B., Krüger, K., Rosa Neto, J. C., Padilha, C. S., Gonçalves, D. C., Minuzzi, L. G., & Lira, F. S. (2022). Feeding pattern, circadian rhythm, and immune function: what do we know about? Current Pharmaceutical Design, 28( 30), 2478-2487. doi:10.2174/1381612828666220729091451
NLM
Estanislau TB, Krüger K, Rosa Neto JC, Padilha CS, Gonçalves DC, Minuzzi LG, Lira FS. Feeding pattern, circadian rhythm, and immune function: what do we know about? [Internet]. Current Pharmaceutical Design. 2022 ; 28( 30): 2478-2487.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612828666220729091451
Vancouver
Estanislau TB, Krüger K, Rosa Neto JC, Padilha CS, Gonçalves DC, Minuzzi LG, Lira FS. Feeding pattern, circadian rhythm, and immune function: what do we know about? [Internet]. Current Pharmaceutical Design. 2022 ; 28( 30): 2478-2487.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612828666220729091451
Artigo de periodico
Modulation of vascular function by perivascular adipose tissue: sex differences (2020)
Victorio, Jamaira A.; Costa, Rafael Menezes da; Tostes, Rita de Cássia Aleixo ; Davel, Ana Paula Couto
Source: Current Pharmaceutical Design. Unidade: FMRP
Subjects: TECIDO ADIPOSO, OBESIDADE, HIPERTENSÃO, DIFERENÇAS SEXUAIS (PSICOGÊNESE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICTORIO, Jamaira A. et al. Modulation of vascular function by perivascular adipose tissue: sex differences. Current Pharmaceutical Design, v. 26, n. 30, p. 3768-3777, 2020Tradução . . Disponível em: https://doi.org/10.2174/1381612826666200701211912. Acesso em: 23 maio 2024.
APA
Victorio, J. A., Costa, R. M. da, Tostes, R. de C. A., & Davel, A. P. C. (2020). Modulation of vascular function by perivascular adipose tissue: sex differences. Current Pharmaceutical Design, 26( 30), 3768-3777. doi:10.2174/1381612826666200701211912
NLM
Victorio JA, Costa RM da, Tostes R de CA, Davel APC. Modulation of vascular function by perivascular adipose tissue: sex differences [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3768-3777.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612826666200701211912
Vancouver
Victorio JA, Costa RM da, Tostes R de CA, Davel APC. Modulation of vascular function by perivascular adipose tissue: sex differences [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3768-3777.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612826666200701211912
Artigo de periodico
Catechins as model bioactive compounds for biomedical applications (2020)
Santos, Adriana Nunes dos ; Nascimento, Tatiana Rita de Lima ; Gondim, Brenna Louise Cavalcanti ; Velo, Marilia Mattar de Amoêdo Campos ; Rêgo, Renaly I. de Araújo ; Carmo Neto, José Rodrigues do ; Machado, Juliana Reis ; Silva, Marcos Vinícius da ; Araújo, Hélvia Walewska Casullo de ; Fonseca, Maria Gardennia da ; Castellano, Lúcio Roberto Cançado
Source: Current Pharmaceutical Design. Unidade: FOB
Subjects: POLIFENÓIS, FÁRMACOS, SAÚDE BUCAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Adriana Nunes dos et al. Catechins as model bioactive compounds for biomedical applications. Current Pharmaceutical Design, v. 26, n. 33, p. 4032-4047, 2020Tradução . . Disponível em: https://doi.org/10.2174/1381612826666200603124418. Acesso em: 23 maio 2024.
APA
Santos, A. N. dos, Nascimento, T. R. de L., Gondim, B. L. C., Velo, M. M. de A. C., Rêgo, R. I. de A., Carmo Neto, J. R. do, et al. (2020). Catechins as model bioactive compounds for biomedical applications. Current Pharmaceutical Design, 26( 33), 4032-4047. doi:10.2174/1381612826666200603124418
NLM
Santos AN dos, Nascimento TR de L, Gondim BLC, Velo MM de AC, Rêgo RI de A, Carmo Neto JR do, Machado JR, Silva MV da, Araújo HWC de, Fonseca MG da, Castellano LRC. Catechins as model bioactive compounds for biomedical applications [Internet]. Current Pharmaceutical Design. 2020 ; 26( 33): 4032-4047.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612826666200603124418
Vancouver
Santos AN dos, Nascimento TR de L, Gondim BLC, Velo MM de AC, Rêgo RI de A, Carmo Neto JR do, Machado JR, Silva MV da, Araújo HWC de, Fonseca MG da, Castellano LRC. Catechins as model bioactive compounds for biomedical applications [Internet]. Current Pharmaceutical Design. 2020 ; 26( 33): 4032-4047.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612826666200603124418
Artigo de periodico-carta/editorial
Immunometabolism disorders: pharmacologic and nonpharmacologic approaches (2020)
Lira, F. S.; Rosa Neto, José Cesar
Source: Current Pharmaceutical Design. Unidade: ICB
Subjects: BIOLOGIA CELULAR, METABOLISMO, DOENÇAS METABÓLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIRA, F. S. e ROSA NETO, José Cesar. Immunometabolism disorders: pharmacologic and nonpharmacologic approaches. Current Pharmaceutical Design. Sharjah: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/138161282609200423142125. Acesso em: 23 maio 2024. , 2020
APA
Lira, F. S., & Rosa Neto, J. C. (2020). Immunometabolism disorders: pharmacologic and nonpharmacologic approaches. Current Pharmaceutical Design. Sharjah: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.2174/138161282609200423142125
NLM
Lira FS, Rosa Neto JC. Immunometabolism disorders: pharmacologic and nonpharmacologic approaches [Internet]. Current Pharmaceutical Design. 2020 ; 26( 9): 905.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/138161282609200423142125
Vancouver
Lira FS, Rosa Neto JC. Immunometabolism disorders: pharmacologic and nonpharmacologic approaches [Internet]. Current Pharmaceutical Design. 2020 ; 26( 9): 905.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/138161282609200423142125
Artigo de periodico
Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction (2020)
Paulo, Michele ; Costa, Daniela E. F. R.; Bonaventura, Daniella; Lunardi, Claure N.; Bendhack, Lusiane Maria
Source: Current Pharmaceutical Design. Unidades: FCFRP, ICB
Subjects: CÉLULAS ENDOTELIAIS, ENDOTÉLIO VASCULAR, ÓXIDO NÍTRICO, FARMACOLOGIA, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULO, Michele et al. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction. Current Pharmaceutical Design, v. 26, n. 30, p. 3748-3759, 2020Tradução . . Disponível em: https://doi.org/10.2174/1381612826666200519114442. Acesso em: 23 maio 2024.
APA
Paulo, M., Costa, D. E. F. R., Bonaventura, D., Lunardi, C. N., & Bendhack, L. M. (2020). Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction. Current Pharmaceutical Design, 26( 30), 3748-3759. doi:10.2174/1381612826666200519114442
NLM
Paulo M, Costa DEFR, Bonaventura D, Lunardi CN, Bendhack LM. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3748-3759.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612826666200519114442
Vancouver
Paulo M, Costa DEFR, Bonaventura D, Lunardi CN, Bendhack LM. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3748-3759.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612826666200519114442
Artigo de periodico
Association between vitamins and minerals with antioxidant effects and coronary artery calcification in adults and older adults: a systematic review (2019)
Machado, Alisson Diego; Andrade, Gustavo Rosa Gentil; Levy, Jessica ; Ferreira, Sara Silva; Marchioni, Dirce Maria Lobo
Source: Current Pharmaceutical Design. Unidades: FSP, FM
Subjects: ANTIOXIDANTES, MAGNÉSIO, VITAMINA E, REVISÃO SISTEMÁTICA, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Alisson Diego et al. Association between vitamins and minerals with antioxidant effects and coronary artery calcification in adults and older adults: a systematic review. Current Pharmaceutical Design, v. 25, n. 22, p. 2474-2479, 2019Tradução . . Disponível em: https://doi.org/10.2174/1381612825666190722101954. Acesso em: 23 maio 2024.
APA
Machado, A. D., Andrade, G. R. G., Levy, J., Ferreira, S. S., & Marchioni, D. M. L. (2019). Association between vitamins and minerals with antioxidant effects and coronary artery calcification in adults and older adults: a systematic review. Current Pharmaceutical Design, 25( 22), 2474-2479. doi:10.2174/1381612825666190722101954
NLM
Machado AD, Andrade GRG, Levy J, Ferreira SS, Marchioni DML. Association between vitamins and minerals with antioxidant effects and coronary artery calcification in adults and older adults: a systematic review [Internet]. Current Pharmaceutical Design. 2019 ;25( 22): 2474-2479.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612825666190722101954
Vancouver
Machado AD, Andrade GRG, Levy J, Ferreira SS, Marchioni DML. Association between vitamins and minerals with antioxidant effects and coronary artery calcification in adults and older adults: a systematic review [Internet]. Current Pharmaceutical Design. 2019 ;25( 22): 2474-2479.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612825666190722101954
Artigo de periodico
X-Ray Characterization of Pharmaceutical and Cosmetic Lipidic Nanoparticles for Cutaneous Application (2019)
Carducci, Federica; Casadei, Bruna Renata; Mariani, Paolo ; Barbosa, Leandro Ramos Souza
Source: Current Pharmaceutical Design. Unidade: IF
Subjects: BIOFÍSICA, LIPÍDEOS, ESPALHAMENTO, RAIOS X
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDUCCI, Federica et al. X-Ray Characterization of Pharmaceutical and Cosmetic Lipidic Nanoparticles for Cutaneous Application. Current Pharmaceutical Design, v. 25 , n. 214, p. 2364-2374, 2019Tradução . . Disponível em: https://doi.org/10.2174/1381612825666190709210211. Acesso em: 23 maio 2024.
APA
Carducci, F., Casadei, B. R., Mariani, P., & Barbosa, L. R. S. (2019). X-Ray Characterization of Pharmaceutical and Cosmetic Lipidic Nanoparticles for Cutaneous Application. Current Pharmaceutical Design, 25 ( 214), 2364-2374. doi:10.2174/1381612825666190709210211
NLM
Carducci F, Casadei BR, Mariani P, Barbosa LRS. X-Ray Characterization of Pharmaceutical and Cosmetic Lipidic Nanoparticles for Cutaneous Application [Internet]. Current Pharmaceutical Design. 2019 ; 25 ( 214): 2364-2374.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612825666190709210211
Vancouver
Carducci F, Casadei BR, Mariani P, Barbosa LRS. X-Ray Characterization of Pharmaceutical and Cosmetic Lipidic Nanoparticles for Cutaneous Application [Internet]. Current Pharmaceutical Design. 2019 ; 25 ( 214): 2364-2374.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612825666190709210211
Artigo de periodico
Current applications of biopolymer-based scaffolds and nanofibers as drug delivery systems (2019)
Nascimento, Tatiana Rita de Lima ; Velo, Marilia Mattar de Amoêdo Campos ; Silva, Camila Félix ; Cruz, Sara Brito Silva Costa ; Gondim, Brenna Louise Cavalcanti ; Mondelli, Rafael Francisco Lia ; Castellano, Lúcio Roberto Cançado
Source: Current Pharmaceutical Design. Unidade: FOB
Subjects: MATERIAIS NANOESTRUTURADOS, BIOPOLÍMEROS, ADMINISTRAÇÃO, FÁRMACOS, PESQUISA BIOMÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Tatiana Rita de Lima et al. Current applications of biopolymer-based scaffolds and nanofibers as drug delivery systems. Current Pharmaceutical Design, v. 25, n. 37, p. 3997-4012, 2019Tradução . . Disponível em: https://doi.org/10.2174/1381612825666191108162948. Acesso em: 23 maio 2024.
APA
Nascimento, T. R. de L., Velo, M. M. de A. C., Silva, C. F., Cruz, S. B. S. C., Gondim, B. L. C., Mondelli, R. F. L., & Castellano, L. R. C. (2019). Current applications of biopolymer-based scaffolds and nanofibers as drug delivery systems. Current Pharmaceutical Design, 25( 37), 3997-4012. doi:10.2174/1381612825666191108162948
NLM
Nascimento TR de L, Velo MM de AC, Silva CF, Cruz SBSC, Gondim BLC, Mondelli RFL, Castellano LRC. Current applications of biopolymer-based scaffolds and nanofibers as drug delivery systems [Internet]. Current Pharmaceutical Design. 2019 ; 25( 37): 3997-4012.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612825666191108162948
Vancouver
Nascimento TR de L, Velo MM de AC, Silva CF, Cruz SBSC, Gondim BLC, Mondelli RFL, Castellano LRC. Current applications of biopolymer-based scaffolds and nanofibers as drug delivery systems [Internet]. Current Pharmaceutical Design. 2019 ; 25( 37): 3997-4012.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612825666191108162948
Artigo de periodico
Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target (2017)
Serrão, Vitor Hugo Balasco; Souza, Juliana Roberta Torini de; Romanello, Larissa; Pereira, Humberto d'Muniz
Source: Current Pharmaceutical Design. Unidade: IFSC
Subjects: SCHISTOSOMA MANSONI, ESQUISTOSSOMOSE, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERRÃO, Vitor Hugo Balasco et al. Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target. Current Pharmaceutical Design, v. 23, n. 45, p. 6967-6983, 2017Tradução . . Disponível em: https://doi.org/10.2174/1381612823666171011100532. Acesso em: 23 maio 2024.
APA
Serrão, V. H. B., Souza, J. R. T. de, Romanello, L., & Pereira, H. d'M. (2017). Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target. Current Pharmaceutical Design, 23( 45), 6967-6983. doi:10.2174/1381612823666171011100532
NLM
Serrão VHB, Souza JRT de, Romanello L, Pereira H d'M. Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target [Internet]. Current Pharmaceutical Design. 2017 ; 23( 45): 6967-6983.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612823666171011100532
Vancouver
Serrão VHB, Souza JRT de, Romanello L, Pereira H d'M. Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target [Internet]. Current Pharmaceutical Design. 2017 ; 23( 45): 6967-6983.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612823666171011100532
Artigo de periodico
Hybrid materials and nanocomposites as multifunctional biomaterials (2017)
Follmann, Heveline D. M.; Naves, Alliny Ferreira; Araujo, Rafael A.; Dubovoy, Viktor; Huang, Xiaoxi; Asefa, Tewodros; Silva, Rafael; Oliveira Junior, Osvaldo Novais de
Source: Current Pharmaceutical Design. Unidade: IFSC
Subjects: NANOCOMPOSITOS, BIOMATERIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOLLMANN, Heveline D. M. et al. Hybrid materials and nanocomposites as multifunctional biomaterials. Current Pharmaceutical Design, v. 23, n. 26, p. 3794-3813, 2017Tradução . . Disponível em: https://doi.org/10.2174/1381612823666170710160615. Acesso em: 23 maio 2024.
APA
Follmann, H. D. M., Naves, A. F., Araujo, R. A., Dubovoy, V., Huang, X., Asefa, T., et al. (2017). Hybrid materials and nanocomposites as multifunctional biomaterials. Current Pharmaceutical Design, 23( 26), 3794-3813. doi:10.2174/1381612823666170710160615
NLM
Follmann HDM, Naves AF, Araujo RA, Dubovoy V, Huang X, Asefa T, Silva R, Oliveira Junior ON de. Hybrid materials and nanocomposites as multifunctional biomaterials [Internet]. Current Pharmaceutical Design. 2017 ; 23( 26): 3794-3813.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612823666170710160615
Vancouver
Follmann HDM, Naves AF, Araujo RA, Dubovoy V, Huang X, Asefa T, Silva R, Oliveira Junior ON de. Hybrid materials and nanocomposites as multifunctional biomaterials [Internet]. Current Pharmaceutical Design. 2017 ; 23( 26): 3794-3813.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612823666170710160615
Artigo de periodico
Challenges and future prospects of nanoemulsion as a drug delivery system (2017)
Yukuyama, Megumi Nishitani; Kato, Edna Tomiko Myiake; Loebenberg, Raimar; Bou-Chacra, Nadia Araci
Source: Current Pharmaceutical Design. Unidade: FCF
Subjects: SOLUBILIDADE, NANOTECNOLOGIA, EMULSÕES (FORMAS FARMACÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKUYAMA, Megumi Nishitani et al. Challenges and future prospects of nanoemulsion as a drug delivery system. Current Pharmaceutical Design, v. 23, n. 3, p. 495-508, 2017Tradução . . Disponível em: https://doi.org/10.2174/1381612822666161027111957. Acesso em: 23 maio 2024.
APA
Yukuyama, M. N., Kato, E. T. M., Loebenberg, R., & Bou-Chacra, N. A. (2017). Challenges and future prospects of nanoemulsion as a drug delivery system. Current Pharmaceutical Design, 23( 3), 495-508. doi:10.2174/1381612822666161027111957
NLM
Yukuyama MN, Kato ETM, Loebenberg R, Bou-Chacra NA. Challenges and future prospects of nanoemulsion as a drug delivery system [Internet]. Current Pharmaceutical Design. 2017 ; 23( 3): 495-508.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612822666161027111957
Vancouver
Yukuyama MN, Kato ETM, Loebenberg R, Bou-Chacra NA. Challenges and future prospects of nanoemulsion as a drug delivery system [Internet]. Current Pharmaceutical Design. 2017 ; 23( 3): 495-508.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612822666161027111957
Artigo de periodico
The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review (2016)
Ghisleni, Daniela Dal Molim; Braga, M. de Souza; Kikuchi, Irene Satiko ; Brasoveanu, M; Nemtanu, Monica Roxana; Dua, Kamal; Pinto, Terezinha de Jesus Andreoli
Source: Current Pharmaceutical Design. Unidade: FCF
Assunto: PLANTAS MEDICINAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GHISLENI, Daniela Dal Molim et al. The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review. Current Pharmaceutical Design, v. 22, n. 27, p. 4264-4287, 2016Tradução . . Disponível em: https://doi.org/10.2174/1381612822666160623070829. Acesso em: 23 maio 2024.
APA
Ghisleni, D. D. M., Braga, M. de S., Kikuchi, I. S., Brasoveanu, M., Nemtanu, M. R., Dua, K., & Pinto, T. de J. A. (2016). The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review. Current Pharmaceutical Design, 22( 27), 4264-4287. doi:10.2174/1381612822666160623070829
NLM
Ghisleni DDM, Braga M de S, Kikuchi IS, Brasoveanu M, Nemtanu MR, Dua K, Pinto T de JA. The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review [Internet]. Current Pharmaceutical Design. 2016 ; 22( 27): 4264-4287.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612822666160623070829
Vancouver
Ghisleni DDM, Braga M de S, Kikuchi IS, Brasoveanu M, Nemtanu MR, Dua K, Pinto T de JA. The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: an in-depth review [Internet]. Current Pharmaceutical Design. 2016 ; 22( 27): 4264-4287.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612822666160623070829
Artigo de periodico
Antisense therapy for cardiovascular diseases (2015)
Ian Phillips, M; Costales, Jessica; J. Lee, Robert; Oliveira, E. M.; B. Burns, Andrew
Source: Current Pharmaceutical Design. Unidade: EEFE
Subjects: DOENÇAS CARDIOVASCULARES, SÍNDROME X METABÓLICA, HIPERTENSÃO, HIPERLIPIDEMIA, EXONS, RNA MENSAGEIRO, OLIGONUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IAN PHILLIPS, M et al. Antisense therapy for cardiovascular diseases. Current Pharmaceutical Design, v. 21, n. 30, p. 4417-4426, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666150803150402. Acesso em: 23 maio 2024.
APA
Ian Phillips, M., Costales, J., J. Lee, R., Oliveira, E. M., & B. Burns, A. (2015). Antisense therapy for cardiovascular diseases. Current Pharmaceutical Design, 21( 30), 4417-4426. doi:10.2174/1381612821666150803150402
NLM
Ian Phillips M, Costales J, J. Lee R, Oliveira EM, B. Burns A. Antisense therapy for cardiovascular diseases [Internet]. Current Pharmaceutical Design. 2015 ; 21( 30): 4417-4426.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612821666150803150402
Vancouver
Ian Phillips M, Costales J, J. Lee R, Oliveira EM, B. Burns A. Antisense therapy for cardiovascular diseases [Internet]. Current Pharmaceutical Design. 2015 ; 21( 30): 4417-4426.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612821666150803150402
Artigo de periodico
Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease (2015)
Maranhão, Raul Cavalcante ; Leite, Antonio Carlos de Arruda
Source: Current Pharmaceutical Design. Unidade: FCF
Subjects: INFLAMAÇÃO, ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante e LEITE, Antonio Carlos de Arruda. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, v. 21, n. 9, p. 1196-1204, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612820666141013150714. Acesso em: 23 maio 2024.
APA
Maranhão, R. C., & Leite, A. C. de A. (2015). Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, 21( 9), 1196-1204. doi:10.2174/1381612820666141013150714
NLM
Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612820666141013150714
Vancouver
Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612820666141013150714
Artigo de periodico
Recent advances of radionuclide-based molecular imaging of atherosclerosis (2015)
Kazuma, Soraya Megumi; Sultan, Deborah; Zhao, Yongfeng; Detering, Lisa; You, Meng; Luehmann, Hannah P; Abdalla, Dulcinéia Saes Parra ; Liu, Yongjian
Source: Current Pharmaceutical Design. Unidade: FCF
Subjects: ARTERIOSCLEROSE, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAZUMA, Soraya Megumi et al. Recent advances of radionuclide-based molecular imaging of atherosclerosis. Current Pharmaceutical Design, v. 21, n. 36, p. 5267-5276, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666150915104529. Acesso em: 23 maio 2024.
APA
Kazuma, S. M., Sultan, D., Zhao, Y., Detering, L., You, M., Luehmann, H. P., et al. (2015). Recent advances of radionuclide-based molecular imaging of atherosclerosis. Current Pharmaceutical Design, 21( 36), 5267-5276. doi:10.2174/1381612821666150915104529
NLM
Kazuma SM, Sultan D, Zhao Y, Detering L, You M, Luehmann HP, Abdalla DSP, Liu Y. Recent advances of radionuclide-based molecular imaging of atherosclerosis [Internet]. Current Pharmaceutical Design. 2015 ; 21( 36): 5267-5276.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612821666150915104529
Vancouver
Kazuma SM, Sultan D, Zhao Y, Detering L, You M, Luehmann HP, Abdalla DSP, Liu Y. Recent advances of radionuclide-based molecular imaging of atherosclerosis [Internet]. Current Pharmaceutical Design. 2015 ; 21( 36): 5267-5276.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612821666150915104529
Artigo de periodico
Protein disulfide isomerase and Nox: new partners in redox signaling (2015)
Trevelin, Silvia Cellone; Lopes, Lucia Rossetti
Source: Current Pharmaceutical Design. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TREVELIN, Silvia Cellone e LOPES, Lucia Rossetti. Protein disulfide isomerase and Nox: new partners in redox signaling. Current Pharmaceutical Design, v. 21, n. 41, p. 5951-5963, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666151029112523. Acesso em: 23 maio 2024.
APA
Trevelin, S. C., & Lopes, L. R. (2015). Protein disulfide isomerase and Nox: new partners in redox signaling. Current Pharmaceutical Design, 21( 41), 5951-5963. doi:10.2174/1381612821666151029112523
NLM
Trevelin SC, Lopes LR. Protein disulfide isomerase and Nox: new partners in redox signaling [Internet]. Current Pharmaceutical Design. 2015 ; 21( 41): 5951-5963.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612821666151029112523
Vancouver
Trevelin SC, Lopes LR. Protein disulfide isomerase and Nox: new partners in redox signaling [Internet]. Current Pharmaceutical Design. 2015 ; 21( 41): 5951-5963.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612821666151029112523
Artigo de periodico
An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health (2015)
Ferrari, Carlos Kusano Bucalen; Percário, Sandro; Silva, José Carlos Costa Baptista; Torres, Elizabeth Aparecida Ferraz da Silva
Source: Current Pharmaceutical Design. Unidade: FSP
Subjects: DOENÇAS CARDIOVASCULARES, TRANSTORNOS CEREBROVASCULARES, SUPLEMENTOS DIETÉTICOS, NEOPLASIAS, FITOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRARI, Carlos Kusano Bucalen et al. An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health. Current Pharmaceutical Design, v. 22, n. 2, p. 189-195, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612822666151117122715. Acesso em: 23 maio 2024.
APA
Ferrari, C. K. B., Percário, S., Silva, J. C. C. B., & Torres, E. A. F. da S. (2015). An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health. Current Pharmaceutical Design, 22( 2), 189-195. doi:10.2174/1381612822666151117122715
NLM
Ferrari CKB, Percário S, Silva JCCB, Torres EAF da S. An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health [Internet]. Current Pharmaceutical Design. 2015 ; 22( 2): 189-195.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612822666151117122715
Vancouver
Ferrari CKB, Percário S, Silva JCCB, Torres EAF da S. An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health [Internet]. Current Pharmaceutical Design. 2015 ; 22( 2): 189-195.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612822666151117122715
Artigo de periodico
Potential of peptide-based enhancers for transdermal delivery (2015)
Lopes, Luciana Biagini ; Carvalho, Vanessa Freitas Mendonça de; Lemos, Débora P. de
Source: Current Pharmaceutical Design. Unidade: ICB
Subjects: FARMACOLOGIA, PEPTIDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Luciana Biagini e CARVALHO, Vanessa Freitas Mendonça de e LEMOS, Débora P. de. Potential of peptide-based enhancers for transdermal delivery. Current Pharmaceutical Design, v. 21, n. 20, p. 2814-2822, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666150428143243. Acesso em: 23 maio 2024.
APA
Lopes, L. B., Carvalho, V. F. M. de, & Lemos, D. P. de. (2015). Potential of peptide-based enhancers for transdermal delivery. Current Pharmaceutical Design, 21( 20), 2814-2822. doi:10.2174/1381612821666150428143243
NLM
Lopes LB, Carvalho VFM de, Lemos DP de. Potential of peptide-based enhancers for transdermal delivery [Internet]. Current Pharmaceutical Design. 2015 ; 21( 20): 2814-2822.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612821666150428143243
Vancouver
Lopes LB, Carvalho VFM de, Lemos DP de. Potential of peptide-based enhancers for transdermal delivery [Internet]. Current Pharmaceutical Design. 2015 ; 21( 20): 2814-2822.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1381612821666150428143243
Artigo de periodico
New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches (2014)
Bueno, Renata Vieria; Braga, Rodolpho de Campos; Segretti, Natanael Dante; Ferreira, Elizabeth Igne ; Trossini, Gustavo Henrique Goulart ; Andrade, Carolina Horta
Source: Current Pharmaceutical Design. Unidade: FCF
Subjects: TUBERCULOSE, ÁCIDOS NUCLEICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Renata Vieria et al. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, v. 20, n. 27, p. 4474-4485, 2014Tradução . . Acesso em: 23 maio 2024.
APA
Bueno, R. V., Braga, R. de C., Segretti, N. D., Ferreira, E. I., Trossini, G. H. G., & Andrade, C. H. (2014). New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, 20( 27), 4474-4485.
NLM
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2024 maio 23 ]
Vancouver
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2024 maio 23 ]

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration